Report Scope:
The current report offers a detailed picture of the high content screening/imaging market.
This report highlights the current and future market potential for high content screening/imaging and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2026, as well as key market players.
This report discusses the high content screening/imaging industry and its various resources. It covers the overall high content screening/imaging market including instrument or platform, consumables (reagents and kits), software and analytics, and services. The report further analyzes the market based on application, providing an analysis of drug discovery, oncology, compound profiling, molecular diagnosis, toxicity studies and neuroscience. A complete regional analysis of the market is also studied in the report.
Based on geography, the market has been segmented into North America, Europe, Asia-Pacific and the Rest of the World (which includes Latin America, and the Middle East and Africa). Detailed analyses of major countries (the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data has been provided for 2020 as the base year, with forecasts for 2021 through 2026. Estimated values are based on product manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.
Report Includes:
- 44 data tables and 28 additional tables
- An overview of the global markets and technologies for high content screening/imaging
- Estimation of the market size and analyses of market trends, with data from 2019, 2020, estimates for 2021 and projection of CAGR through 2026
- Quantification of high content screening/imaging market based on component, end user, application, and region, and analysis of market drivers, restraints and other forces impacting the global market
- Highlights of the current and future market potential, detailed analysis of the regulatory framework and policies and information on new technologies and innovations of the industry
- Discussion on advantages of high-throughput screening over manual screening, and COVID-19 impact on MedTech and medical tourism
- Coverage of recent developments, research and development (R&D) exploration, clinical trials and government programs to predict market trends of the HCS/I market
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
- Company profiles of major players, including Molecular Devices (Danaher), Thermo Fisher Scientific, Becton, Dickinson and Co., PerkinElmer Inc., Genedata AG, and Yokogawa Electric Corp.
Summary:
The global market for high content screening/imaging was valued at $REDACTED billion in 2020. The market is expected to grow at a compound annual growth rate (CAGR) of REDACTED% to reach $REDACTED billion by 2026. The major factor contributing to the growth of the HCS/I market is the rising adoption of high content screening/imaging technology in research and development activities. The rapid adoption of HCS/Itechnology in the pharmaceutical industry and academic research centers indicates the importance ofthis information-rich screening tool. The imaging of cell function has become increasingly important tounderstand the underlying functional biology associated with new therapeutic targets. Demand forimproved technologies for cell research, government support and emergence of sophisticatedinformatics solutions, along with rising demand for better screening systems, is augmenting the demandfor high content imaging within fully automated screening laboratories. Furthermore, technologicaladvancements and developments in biological research and the discovery of more effective therapiesfor the treatment of human disease are fueling the growth of the market. HCS/I systems havecontinually evolved with many improvements enabled to meet user demands of greater flexibility andthe growing requirements of assays involving complex cellular disease models. Increasing drug discoveryR&D globally, increasing investments and introduction of advanced imaging instruments are the otherdrivers for the HCS/I market.
The high cost of HCS/I instrumentation is the primary factor restraining the growth of the market. The price of machinery and instrumentation prohibits a small economy country or a research organization from purchasing HCS/I equipment. Companies are introducing more sensitive cameras and better light sources, such as LED and multicolor illumination, which are increasing the output and reliability of the system and, therefore, the overall cost of the microscopes. The price of HCS/I equipment varies from a hundred thousand to a million dollars, depending on the specifications. Inadequate infrastructure and less funding for R&D in emerging countries will also hinder the market as installation and maintenance costs are also very high and not easily feasible for emerging economies.
Adoption of HCS/I in the analysis of 3D spheroids, microtissues and phenotypic assays, are expected to impact gene editing studies based on CRISPR-Cas9 in the future. Moreover, the growing availability of perturbagen libraries and HCS/I infrastructure within academic research centers has prompted widespread interest in HCS/I applications among academic investigators. The combination of HCS/I with chemical genetics, where small organic molecules are used to study biological systems has emerged as a powerful approach for defining protein functions and dissecting signaling pathways. The rapid growth of genome-wide RNA interference (RNAi) technology to probe gene function in mammalian cell culture systematically has popularized HCS/I systems in academic research environments.
High Content Screening/Imaging: Technologies and Global Markets
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
What's New in this Report?
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Overview
Chapter 3 Market and Technology Background
Overview
Scanning Probe Microscopy
Scanning Electron Microscopy
Transmission Electron Microscopy
Technological Advancements
Cytometers
Detectors/Sensors
Liquid Handling Instruments
Process Overview
High Content Screening (HCS)
High Throughput Screening (HTS)
Chapter 4 Impact of COVID-19 Pandemic
Introduction
Impact on MedTech
Elective and Noncritical Procedures
Shift in Manufacturing
Regulatory Delays, Clinical Trials and Product Launches
Supply Chain Disruptions
Medical Tourism
Chapter 5 Market Dynamics
Market Drivers
Increasing R&D Budget
Advantages Over Manual and High-Throughput Screening
Technological Advancements in High Content Screening/Imaging
Market Restraints
Expensive Equipment
Inadequate Infrastructure and Funding for R&D in Emerging Countries
Market Opportunities
Opportunities in Various 3D Applications
Emerging Economies
Chapter 6 Market Breakdown by Component
Instruments and Platforms
Imaging Devices
Cytometers
Plate Readers
Light Sources
Detectors/Sensors
Liquid Handling Instruments
Market Size and Forecast
Consumables (Reagents and Kits)
Market Size and Forecast
Software and Analytics
Store Image and Database Management Software by Thermo Fisher Scientific
OpenHiCAMM (Open Hi Content Acquisition for µManager) Software
Market Size and Forecast
Services
siRNA Screens
Analysis of Fluorescent Cellular Assay
Robotic Liquid and Microplate Handling
Market Size and Forecast
Chapter 7 Market Breakdown by Application
Global Market for High Content Screening/Imaging by Application
Drug Discovery
Oncology
Compound Profiling
Molecular Diagnosis
Toxicity Studies
Neuroscience
Chapter 8 Market Breakdown by End User
Global Market for High Content Screening/Imaging by End User
Companies
Academics
Laboratories and Pathology Centers
Chapter 9 Market Breakdown by Region
Global Market for High Content Screening/Imaging by Region
North America
Europe
Asia-Pacific
Rest of the World (RoW)
Chapter 10 Patent Review
Introduction
Patents Issued by Publication Year, 2015-2017
Chapter 11 Competitive Landscape
Overview
Company Share Analysis
Strategies
Regional Distributors
End Users
Recent Developments
Chapter 12 Pricing Analysis of Instruments by Major Players
Thermo Fisher Scientific
Molecular Devices (Danaher)
Yokogawa Electric Corp.
BioTek (Agilent)
Essen Bioscience (Sartorius)
Logos Biosystems
Other Major Players
Chapter 13 Company Profiles
ALBANY MOLECULAR RESEARCH INC. (AMRI)
AURELIA BIOSCIENCE LTD.
AXXAM SPA
BECTON, DICKINSON AND CO.
BIOTEK INSTRUMENTS INC.
CHARLES RIVER
CORNING INC.
CREATIVE BIOLABS
CURIOX BIOSYSTEMS INC.
CYTOO SA
DANAHER CORP.
DE NOVO SOFTWARE
DISCOVERX CORP.
ESSEN BIOSCIENCE
FLUXION BIOSCIENCES
GENEDATA AG
HUDSON ROBOTICS INC.
INSTRUMENT SYSTEMS
LUMENCOR INC.
MERCK MILLIPORE
OLYMPUS CORP.
PERKINELMER INC.
PHENOVISTA BIOSCIENCES LLC
PLATYPUS TECHNOLOGIES
TECAN GROUP LTD.
THERMO FISHER SCIENTIFIC INC.
THORLABS INC.
VALA SCIENCES INC.
YOKOGAWA ELECTRIC CORP.
List of Tables
Summary Table : Global Market for High Content Screening/Imaging Technology, by Region, Through 2026
Table 1 : Microscopes Used in High Content Screening/Imaging
Table 2 : HTS Detection Methods
Table 3 : Comparison of Cellomics with Other Omics Techniques
Table 4 : Global Market for High Content Screening/Imaging, by Component, Through 2026
Table 5 : Global Market for High Content Screening/Imaging Instruments and Platforms, by Segment, Through 2026
Table 6 : High Content Screening/Imaging Platforms, by Thermo Fisher Scientific
Table 7 : Cytometers
Table 8 : Microplate Readers Available in the Market and Their Manufacturers
Table 9 : Fluorescent Dyes Used for the Sensor Array
Table 10 : Automated Liquid Handling Modules
Table 11 : Global Market for High Content Screening/Imaging Instruments and Platforms, by Region, Through 2026
Table 12 : Specification of HCS Live/Dead Green Kit
Table 13 : Global Market for High Content Screening/Imaging Consumables (Reagents and Kits), by Region, Through 2026
Table 14 : Global Market for High Content Screening/Imaging Software and Analytics, by Region, Through 2026
Table 15 : Global Market for High Content Screening/Imaging Services, by Region, Through 2026
Table 16 : Global Market for High Content Screening/Imaging, by Application, Through 2026
Table 17 : Global Market for High Content Screening/Imaging in Drug Discovery Applications, by Region, Through 2026
Table 18 : Global Market for High Content Screening/Imaging in Oncology Applications, by Region, Through 2026
Table 19 : Global Market for High Content Screening/Imaging in Compound Profiling Applications, by Region, Through 2026
Table 20 : Global Market for High Content Screening/Imaging in Molecular Diagnosis Applications, by Region, Through 2026
Table 21 : Global Market for High Content Screening/Imaging in Toxicity Studies, by Region, Through 2026
Table 22 : Global Market for High Content Screening/Imaging in Neuroscience Applications, by Region, Through 2026
Table 23 : Global Market for High Content Screening/Imaging, by End User, Through 2026
Table 24 : Global Market for High Content Screening/Imaging for Company End Users, by Region, Through 2026
Table 25 : Institutes with High Content Screening/Imaging Facilities
Table 26 : Global Market for High Content Screening/Imaging for Academic End Users, by Region, Through 2026
Table 27 : Global Market for High Content Screening/Imaging for Laboratory and Pathology Center End Users, by Region, Through 2026
Table 28 : Global Market for High Content Screening/Imaging, by Region, Through 2026
Table 29 : North American Market for High Content Screening/Imaging, by Component, Through 2026
Table 30 : North American Market for High Content Screening/Imaging Instruments and Platforms, by Segment, Through 2026
Table 31 : North American Market for High Content Screening/Imaging, by Application, Through 2026
Table 32 : North American Market for High Content Screening/Imaging, by End User, Through 2026
Table 33 : North American Market for High Content Screening/Imaging, by Country, Through 2026
Table 34 : Estimated Number of New Cancer Cases in the U.S., by Cancer Site, 2021
Table 35 : European Market for High Content Screening/Imaging, by Component, Through 2026
Table 36 : European Market for High Content Screening/Imaging Instruments and Platforms, by Segment, Through 2026
Table 37 : European Market for High Content Screening/Imaging, by Application, Through 2026
Table 38 : European Market for High Content Screening/Imaging, by End User, Through 2026
Table 39 : European Market for High Content Screening/Imaging, by Country, Through 2026
Table 40 : Asia-Pacific Market for High Content Screening/Imaging, by Component, Through 2026
Table 41 : Asia-Pacific Market for High Content Screening/Imaging Instruments and Platforms, by Segment, Through 2026
Table 42 : Asia-Pacific Market for High Content Screening/Imaging, by Application, Through 2026
Table 43 : Asia-Pacific Market for High Content Screening/Imaging, by End User, Through 2026
Table 44 : Japanese Market Statistics
Table 45 : Vaccine Manufacturers in India
Table 46 : Rest of the World Market for High Content Screening/Imaging, by Component, Through 2026
Table 47 : Rest of the World Market for High Content Screening/Imaging, by Segment, Through 2026
Table 48 : Rest of the World Market for High Content Screening/Imaging, by Application, Through 2026
Table 49 : Rest of the World Market for High Content Screening/Imaging, by End User, Through 2026
Table 50 : Number of Patents Issued for High content Screening/Imaging Technology, by Key Company/Assignee
Table 51 : Number of Patents Issued for High Content Screening/Imaging Technology, by Category, 2015-2017
Table 52 : Number of Patents Issued for High Content Screening/Imaging Technology, by Assignee's Country, 2015-2017
Table 53 : Number of Patents Issued for High Content Screening/Imaging Technology, by Publication Year, 2015-2017
Table 54 : Patents Issued for High Content Screening/Imaging Technology, January 2015-December 2017
Table 55 : Thermo Fisher Scientific Products Covered, by One or More Patents
Table 56 : Patents on Molecular Devices Patents, 2015-2017
Table 57 : Recent Developments in the High Content Screening/Imaging Technology Market, 2017-2021
Table 58 : Average Selling Price of Products, Thermo Fisher Scientific
Table 59 : Average Selling Price of Products, Molecular Devices
Table 60 : Average Selling Price of Products, Yokogawa Electric Corp
Table 61 : Average Selling Price of Products, BioTek (Agilent)
Table 62 : Average Selling Price of Products, Essen Bioscience (Sartorius)
Table 63 : Average Selling Price of Products, Logos Biosystems
Table 64 : Average Selling Price of Products, Other Players
Table 65 : BD: Product Portfolio
Table 66 : BioTek Instruments: Product Portfolio
Table 67 : Corning Inc.: Product Portfolio
Table 68 : CYTOO SA: Product Portfolio
Table 69 : Essen BioScience: Product Portfolio
Table 70 : Olympus Corp.: Product Portfolio
Table 71 : Thermo Fisher Scientific: Product Portfolio
List of Figures
Summary Figure A : Global Market for High Content Screening/Imaging Technology, by Region, 2019-2026
Summary Figure B : Global Market Shares of High Content Screening/Imaging Technology, by Region, 2020
Figure 1 : Approaches for Imaging Sample Surfaces
Figure 2 : HCS in Drug Discovery
Figure 3 : Four Steps of Data Analysis
Figure 4 : Basic Tools for High Content Screening
Figure 5 : Advantages of HTS
Figure 6 : Applications of High-Throughput Screening
Figure 7 : Software Utilized for Data Analysis
Figure 8 : Flow of Funding for Disease Research, 2014-2018
Figure 9 : Share of Investments in Drug Discovery and Clinical Research, by Funding Category, 2018
Figure 10 : Technological Advancements in High Content Screening
Figure 11 : Global Market Shares of High Content Screening/Imaging, by Component, 2020
Figure 12 : Global Market for High Content Screening/Imaging, by Component, 2019-2026
Figure 13 : Global Market Shares of High Content Screening/Imaging Instruments and Platforms, by Component, 2020
Figure 14 : Key Benefits of Vectra Polaris Imaging Device
Figure 15 : Five Main Components of a Flow Cytometer
Figure 16 : Microplate Reader Categories
Figure 17 : Global Market for High Content Screening/Imaging Instruments and Platforms, 2019-2026
Figure 18 : Global Market for High Content Screening/Imaging Instruments and Platforms, by Region, 2019-2026
Figure 19 : Features of Thiol Tracker Violet
Figure 20 : Global Market for High Content Screening/Imaging Consumables (Reagents and Kits), 2019-2026
Figure 21 : Global Market for High Content Screening/Imaging Consumables (Reagents and Kits), by Region, 2019-2026
Figure 22 : Features of HCS Studio 2.0 Cell Analysis Software
Figure 23 : Features of Store Image and Database Management Software
Figure 24 : Key Features of OpenHiCAMM
Figure 25 : OpenHiCAMM: High Content Screening/Imaging Software for Complex Microscope Imaging Workflows
Figure 26 : Global Market for High Content Screening/Imaging Software and Analytics, 2019-2026
Figure 27 : Global Market for High Content Screening/Imaging Software and Analytics, by Region, 2019-2026
Figure 28 : Analysis of a Fluorescent Cellular Assay
Figure 29 : Global Market for High Content Screening/Imaging Services, 2019-2026
Figure 30 : Global Market for High Content Screening/Imaging Services, by Region, 2019-2026
Figure 31 : Global Market Shares of High Content Screening/Imaging, by Application, 2020
Figure 32 : Drug Discovery Cycle
Figure 33 : Features of the Lead Compound
Figure 34 : Timeline of Drug Discovery and Development
Figure 35 : Global Market for High Content Screening/Imaging in Drug Discovery Applications, 2019-2026
Figure 36 : Global Market for High Content Screening/Imaging in Drug Discovery Applications, by Region, 2019-2026
Figure 37 : Global Market for High Content Screening/Imaging in Oncology Applications, 2019-2026
Figure 38 : Global Market for High Content Screening/Imaging in Oncology Applications, by Region, 2019-2026
Figure 39 : Strategies to Improve Screening Using Compound Profiling
Figure 40 : Global Market for High Content Screening/Imaging in Compound Profiling Applications, 2019-2026
Figure 41 : Global Market for High Content Screening/Imaging in Compound Profiling Applications, by Region, 2019-2026
Figure 42 : Global Market for High Content Screening/Imaging in Molecular Diagnosis Applications, 2019-2026
Figure 43 : Global Market for High Content Screening/Imaging in Molecular Diagnosis Applications, by Region, 2019-2026
Figure 44 : Types of Toxicity Studies
Figure 45 : Global Market for High Content Screening/Imaging in Toxicity Studies, 2019-2026
Figure 46 : Global Market for High Content Screening/Imaging in Toxicity Studies, by Region, 2019-2026
Figure 47 : Global Market for High Content Screening/Imaging in Neuroscience Applications, 2019-2026
Figure 48 : Global Market for High Content Screening/Imaging in Neuroscience Applications, by Region, 2019-2026
Figure 49 : Global Market Shares of High Content Screening/Imaging, by End User, 2020
Figure 50 : Global Market for High Content Screening/Imaging for Company End Users, 2019-2026
Figure 51 : Global Market for High Content Screening/Imaging for Company End Users, by Region, 2019-2026
Figure 52 : Global Market for High Content Screening/Imaging for Academic End Users, 2019-2026
Figure 53 : Global Market for High Content Screening/Imaging for Academic End Users, by Region, 2019-2026
Figure 54 : Global Market for High Content Screening/Imaging for Laboratory and Pathology Center End Users, 2019-2026
Figure 55 : Global Market for High Content Screening/Imaging for Laboratory and Pathology Center End Users, by Region, 2019-2026
Figure 56 : Global Market for High Content Screening/Imaging, by Region, 2019-2026
Figure 57 : Global Market Shares of High Content Screening/Imaging, by Region, 2020
Figure 58 : North American Market Shares of High Content Screening/Imaging, by Component, 2020
Figure 59 : North American Market Shares of High Content Screening/Imaging, by Application, 2020
Figure 60 : North American Market Shares of High Content Screening/Imaging, by End User, 2020
Figure 61 : North American Market Shares of High Content Screening/Imaging, by Country, 2020
Figure 62 : U.S. Market for High Content Screening/Imaging, 2019-2026
Figure 63 : Number of New Cancer Cases in Canada, by Cancer Site, 2020
Figure 64 : Canadian Market for High Content Screening/Imaging, 2019-2026
Figure 65 : European Market Shares of High Content Screening/Imaging, by Component, 2020
Figure 66 : European Market Shares of High Content Screening/Imaging, by Application, 2020
Figure 67 : European Market Shares of High Content Screening/Imaging, by End User, 2020
Figure 68 : European Market Shares of High Content Screening/Imaging, by Country, 2020
Figure 69 : German Market for High Content Screening/Imaging, 2019-2026
Figure 70 : U.K. Market for High Content Screening/Imaging, 2019-2026
Figure 71 : Share of New Cancer Cases in France, by Cancer Site, 2020
Figure 72 : French Market for High Content Screening/Imaging, 2019-2026
Figure 73 : Number of New Cancer Cases in Italy, by Cancer Site, 2020
Figure 74 : Italian Market for High Content Screening/Imaging, 2019-2026
Figure 75 : Share of New Cancer Cases in Spain, by Cancer Site, 2020
Figure 76 : Spanish Market for High Content Screening/Imaging, 2019-2026
Figure 77 : Rest of the European Market for High Content Screening/Imaging, 2019-2026
Figure 78 : Asia-Pacific Market Shares of High Content Screening/Imaging, by Component, 2020
Figure 79 : Asia-Pacific Market Shares of High Content Screening/Imaging, by Application, 2020
Figure 80 : Asia-Pacific Market Shares of High Content Screening/Imaging, by End User, 2020
Figure 81 : Number of New Cancer Cases in China, by Cancer Site, 2020
Figure 82 : Shares of New Cancer Cases in China, by Cancer Site, 2020
Figure 83 : Chinese Market for High Content Screening/Imaging, 2019-2026
Figure 84 : Japanese Market for High Content Screening/Imaging, 2019-2026
Figure 85 : Indian Market for High Content Screening/Imaging, 2019-2026
Figure 86 : Rest of Asia-Pacific Market for High Content Screening/Imaging, 2019-2026
Figure 87 : Rest of the World Market Shares of High Content Screening/Imaging, by Component, 2020
Figure 88 : Rest of the World Market Shares of High Content Screening/Imaging, by Application, 2020
Figure 89 : Rest of the World Market Shares of High Content Screening/Imaging, by End User, 2020
Figure 90 : Rest of the World Market for High Content Screening/Imaging, 2019-2026
Figure 91 : Global Market Shares of High Content Screening/Imaging Technology, by Manufacturer/Supplier, 2020
Figure 92 : Strategies Adopted, by Key Market Players
Figure 93 : BD: Annual Revenue, 2018-2020
Figure 94 : BD: Revenue Share, by Geography, 2020
Figure 95 : BD: Revenue Share, by Business Segment, 2020
Figure 96 : BioTek Instruments (Agilent Technologies): Annual Revenue, 2018-2020
Figure 97 : Charles River Laboratories: Annual Revenue, 2018-2020
Figure 98 : Charles River Laboratories: Revenue Share, by Region, 2020
Figure 99 : Corning Inc.: Annual Revenue, 2018-2020
Figure 100 : Danaher Corp.: Annual Revenue, 2018-2020
Figure 101 : Danaher Corp.: Revenue Share, by Geography, 2020
Figure 102 : Danaher Corp.: Revenue Share, by Segment, 2020
Figure 103 : Eurofins Pharma Discovery Services (Eurofins DiscoverX Products): Annual Revenue, 2018-2020
Figure 104 : Merck KGaA: Annual Revenue, 2019-2020
Figure 105 : Merck KGaA: Revenue Share, by Region, 2020
Figure 106 : Merck KGaA: Revenue Share, by Business Segment, 2020
Figure 107 : Olympus Corp.: Annual Revenue, 2018-2020
Figure 108 : PerkinElmer Inc.: Annual Revenue, 2017-2020
Figure 109 : PerkinElmer Inc.: Revenue Share, by Region, 2020
Figure 110 : PerkinElmer Inc.: Revenue Shares, by Business Unit, 2020
Figure 111 : Tecan Trading AG: Annual Revenue, 2017-2020
Figure 112 : Tecan Trading AG: Revenue Share, by Region, 2020
Figure 113 : Tecan Trading AG: Revenue Shares, by Business Unit, 2020
Figure 114 : Thermo Fisher Scientific: Annual Revenue, 2019-2020
Figure 115 : Thermo Fisher Scientific: Revenue Share, by Region, 2020
Figure 116 : Thermo Fisher Scientific: Revenue Share, by Segment, 2020
Figure 117 : Yokogawa Electric Corp.: Annual Revenue, 2018-2019
Figure 118 : Yokogawa Electric Corp.: Revenue Share, by Business Unit, 2020
Global High Content Screening Market Research Report 2024 (Status and Outlook)
Published: 15-Dec-2023 Price: US 3200 Onwards Pages: 124
Report Overview:
High-content screening (HCS) or high-content analysis (HCA) (also known as cellomics), is a set of analytical techniques that is applied in genetic research and drug discovery processes in order to recognize elements such as peptides, small molecules, or genetic materials (such as RNAi) that have the potential to modify the phenotype of a cell in a certain manner. High-content screening employs a set of analytical procedures such as multi-parameter image processing, automa......
Global Fragment-Based Drug Discovery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 07-Dec-2023 Price: US 3380 Onwards Pages: 108
Market Overview of Global Fragment-Based Drug Discovery market:
According to our latest research, the global Fragment-Based Drug Discovery market looks promising in the next 5 years. As of 2022, the global Fragment-Based Drug Discovery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
Global High Throughput Screening Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 28-Nov-2023 Price: US 3380 Onwards Pages: 111
Market Overview of Global High Throughput Screening market:
According to our latest research, the global High Throughput Screening market looks promising in the next 5 years. As of 2022, the global High Throughput Screening market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
High throughput screening refers to the experimental method based on molecular and cellular levels, using microplate......
Global High Content Screening Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 09-Nov-2023 Price: US 3380 Onwards Pages: 111
Market Overview of Global High Content Screening market:
According to our latest research, the global High Content Screening market looks promising in the next 5 years. As of 2022, the global High Content Screening market was estimated at USD 579.78 million, and it's anticipated to reach USD 1216.18 million in 2028, with a CAGR of 13.14% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the ......
Global Botanical and Plant Derived Drugs Market Insights, Forecast to 2029
Published: 14-Aug-2023 Price: US 4900 Onwards Pages: 88
Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi. They are used in treatment of various diseases, such as central nervous system disorders, cardiovascular diseases, infectious diseases and respiratory diseases. Botanical drugs are available in vari......
Global High Content Screening Market Insights, Forecast to 2029
Published: 11-Aug-2023 Price: US 4900 Onwards Pages: 110
High-content screening (HCS) or high-content analysis (HCA) (also known as cellomics), is a set of analytical techniques that is applied in genetic research and drug discovery processes in order to recognize elements such as peptides, small molecules, or genetic materials (such as RNAi) that have the potential to modify the phenotype of a cell in a certain manner. High-content screening employs a set of analytical procedures such as multi-parameter image processing, automated microscopy, fluores......
Global High Throughput Screening Market Insights: Impact of COVID-19 and Future Expectations to 2028
Published: 27-Jun-2023 Price: US 3260 Onwards Pages: 115
High throughput screening refers to the experimental method based on molecular and cellular levels, using microplate as an experimental tool carrier, performing the test process with an automated operating system, collecting experimental results data with sensitive and rapid detection instruments, and processing experiments with computer analysis. Data, testing tens of millions of samples at the same time, and supporting the running technical system with the corresponding database, it is charact......
Global Fragment-based Drug Discovery Market Insights, Forecast to 2029
Published: 31-May-2023 Price: US 4900 Onwards Pages: 111
The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices.
Market Analysis and Insights: Global Fragment-based Drug Discovery Market
The global Fragment-based Drug Discovery market is projected to grow from US$ 365.8 million in 2023 to US$ 533.8 million by 2029, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period.
The US & Cana......
High Throughput Screening Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030
Published: 05-May-2023 Price: US 4150 Onwards Pages: 146
The study predicts the short term and long term trends that can shape up the future of the High Throughput Screening market including the COVID-19 pandemic implications for High Throughput Screenings industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets a......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
